设为首页         

资讯内容 Content

[ESC2009]ACCOMPLISH研究的应用及单片复方制剂(SPC)在高血压治疗中的地位--Weber教授专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

 编辑:国际循环网 时间:2009/9/3 18:26:00    加入收藏
 关键字:ACCOMPLISH 单片复方制剂 倍博特 阿利吉仑 


International Circulation:  May I have your opinion about the position of SPC in antihypertensive therapy?

国际循环:可否谈谈您对SPC降压疗效的看法?

Michael Weber:  The Food and Drug Administration, in essence, has said whenever a doctor believes that the benefits of quick and effective blood pressure reduction are compelling and outweigh any possible concerns about perhaps excessive blood pressure reduction, which frankly we never really see with the use of these agents, then doctors should feel empowered to go ahead with that strategy.  As we have discussed, it has been highly effective.

Michael Weber教授:据食品和药品监督管理局报道,医生确信快速、有效降压的获益是强制性的,优于可能的过度降压。坦白的讲,我们还从未遇到过这种现象,由此更加深了医生先前的观点。正如我们已讨论过的,SPC确实非常有效。



上一页  [1]  [2]  [3]  [4]  [5]  下一页

   评论发言          
 
京ICP备15014970号-5   国际循环 版权所有  2008-2022 icirculation.com  All Rights Reserved